AI assistant
CODEXIS, INC. — Director's Dealing 2010
Apr 29, 2010
33607_dirs_2010-04-29_2adc5426-2ce6-4cd2-b311-f964d3a4fbf8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CODEXIS INC (CDXS)
CIK: 0001200375
Period of Report: 2010-04-27
Reporting Person: SULAT JAMES R (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-27 | Common Stock | C | 4040404 | — | Acquired | 4707070 | Indirect |
| 2010-04-27 | Common Stock | C | 1080146 | — | Acquired | 5787216 | Indirect |
| 2010-04-27 | Common Stock | C | 169892 | — | Acquired | 5957108 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-04-27 | Series A Preferred Stock | $ | C | 4040404 | Disposed | Common Stock (4040404) | Direct | |
| 2010-04-27 | Series B Preferred Stock | $ | C | 1080146 | Disposed | Common Stock (1080146) | Direct | |
| 2010-04-27 | Series D Preferred Stock | $ | C | 169892 | Disposed | Common Stock (169892) | Direct | |
| 2010-04-27 | Warrant to Purchase Series D Preferred Stock | $5.96 | J | 30816 | Disposed | 2013-05-25 | Series D Preferred Stock (30816) | Direct |
| 2010-04-27 | Warrant to Purchase Common Stock | $5.96 | J | 30816 | Acquired | 2013-05-25 | Common Stock (30816) | Direct |
Footnotes
F1: Reflects a 2-for-3 reverse stock split of the Issuer's outstanding securities effected immediately prior to the effectiveness of the Issuer's S-1 Registration Statement (Commission File No. 333-164044).
F2: Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.010101-for-1 basis upon the closing of the Issuer's initial public offering.
F3: Held by Maxygen, Inc. ("Maxygen"). James R. Sulat, a member of the Issuer's board of directors, is the Chief Executive Officer, Chief Financial Officer and a member of the board of directors of Maxygen, and, as such, may be deemed to be the beneficial owner of the securities held by Maxygen. Mr. Sulat disclaims beneficial ownership of all securities held by Maxygen, except to the extent of his pecuniary interest therein.
F4: Each share of Series B Preferred Stock automatically converted into Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
F5: Each share of Series D Preferred Stock automatically converted into Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
F6: The expiration date is not relevant to the conversion of these securities.
F7: Upon completion of the Issuer's initial public offering, the warrant to purchase shares of Series D Preferred Stock automatically converted into a warrant to purchase an equal number of shares of the Issuer's Common Stock. Disposition of Warrant to Series D Preferred Stock and acquisition of Warrant to Purchase Common Stock listed solely for the purpose of reporting such conversion of the shares underlying the security.
F8: This warrant is immediately exercisable.